摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(Decyloxy)benzoic acid | 79785-46-9

中文名称
——
中文别名
——
英文名称
3-(Decyloxy)benzoic acid
英文别名
3-decoxybenzoic acid
3-(Decyloxy)benzoic acid化学式
CAS
79785-46-9
化学式
C17H26O3
mdl
——
分子量
278.392
InChiKey
GQQMIUHFDWGLCQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    412.4±18.0 °C(Predicted)
  • 密度:
    1.014±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    20
  • 可旋转键数:
    11
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(Decyloxy)benzoic acid氯化亚砜N,N-二甲基甲酰胺盐酸羟胺 作用下, 以 二氯甲烷四氢呋喃 为溶剂, 反应 3.08h, 生成 3-(decyloxy)-N-hydroxybenzamide
    参考文献:
    名称:
    Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model
    摘要:
    Acid sphingomyelinase (ASM) has been shown to be involved in many physiological processes, emerging to be a promising drug target. In this study, we constructed a ligand-based pharmacophore model of ASM inhibitors and applied this model to optimize the lead compound alpha-mangostin, a known inhibitor of ASM. 23 compounds were designed and evaluated in vitro for ASM inhibition, of these, 10 compounds were found to be more potent than alpha-mangostin. This high hit ratio confirmed that the presented model is very effective and practical. The most potent hit, 1c, was found to selectively and competitively inhibit the enzyme and inhibit the generation of ceramide in a dose-dependent manner. Furthermore, 1c showed favorable anti-apoptosis and anti-inflammatory activity. Interactions with key residues and the Zn2+ cofactor of 1c were found by docking simulation. These results provide promising leads and important guidance for further development of efficient ASM inhibitors and drug candidates. (C) 2018 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2018.03.065
  • 作为产物:
    描述:
    3-羟基苯甲酸甲酯potassium carbonate 、 potassium hydroxide 作用下, 以 乙醇乙腈 为溶剂, 生成 3-(Decyloxy)benzoic acid
    参考文献:
    名称:
    取代模式和链长对烷氧基取代三苯基三唑并三嗪热致性质的影响
    摘要:
    通过 DSC、偏光光学显微镜 (POM) 和 X 射线散射制备并研究了具有三重烷氧基苯基取代的三三唑并三嗪 (TTT)。六个戊氧基链足以在这些星形化合物中诱导液晶行为。比较了具有不同取代模式和不同长度的线性链外围、链中分支和燕尾的 TTT 的热致性质。一般来说,这些盘显示出广泛且稳定的热致中间相,切向 TTT 优于径向异构体。研究了烷基链的数量、位置、长度和结构的构效关系。
    DOI:
    10.3390/molecules25235761
点击查看最新优质反应信息

文献信息

  • N-substituted glycines, inhibitors of phospholipase A.sub.2
    申请人:Hoffmann-La Roche Inc.
    公开号:US05298652A1
    公开(公告)日:1994-03-29
    Compounds of the formula ##STR1## R is hydrogen or --CH.sub.2 COOH; m is 0-2, x is 1-2, with the provision that when x is 2, m is always 0; R.sub.1 is CH.sub.3 (CH.sub.2).sub.n O--, CH.sub.3 (CH.sub.2).sub.n CONH--, CH.sub.3 (CH.sub.2).sub.n NHCONH--, CH.sub.3 (CH.sub.2).sub.n NHCOO--, HOOC(CH.sub.2).sub.p O-- or R.sub.3 (CH.sub.2).sub.q O--; R.sub.2 is hydrogen, carboxy, hydroxy, nitro, amino, CH.sub.3 (CH.sub.2).sub.n O--, CH.sub.3 (CH.sub.2).sub.n CONH--, CH.sub.3 (CH.sub.2).sub.n NHCONH--, CH.sub.3 (CH.sub.2).sub.n NHCOO--, HOOC(CH.sub.2).sub.p O--, R.sub.3 (CH.sub.2).sub.q O-- or R.sub.4 [O(CH.sub.2).sub.2 ].sub.r O--, wherein n is 0-17, p is 1-10, q is 1-12, r is 1-6, R.sub.3 is 1- or 2- naphthyloxy, 2,3- or 3,4-dihydroxyphenyl, phenyl, phenoxy or substituted phenyl or phenoxy, wherein the substituent is selected from the group consisting of lower alkyl, lower alkoxy, hydroxy, nitro, amino, halo, carboxy or phenyl, and R.sub.4 is lower alkyl; and pharmaceutically acceptable salts with bases, are described.
    式为##STR1##的化合物;R为氢或--CH.sub.2 COOH;m为0-2,x为1-2,但当x为2时,m始终为0;R.sub.1为CH.sub.3 (CH.sub.2).sub.n O--,CH.sub.3 (CH.sub.2).sub.n CONH--,CH.sub.3 (CH.sub.2).sub.n NHCONH--,CH.sub.3 (CH.sub.2).sub.n NHCOO--,HOOC(CH.sub.2).sub.p O--或R.sub.3 (CH.sub.2).sub.q O--;R.sub.2为氢,羧基,羟基,硝基,氨基,CH.sub.3 (CH.sub.2).sub.n O--,CH.sub.3 (CH.sub.2).sub.n CONH--,CH.sub.3 (CH.sub.2).sub.n NHCONH--,CH.sub.3 (CH.sub.2).sub.n NHCOO--,HOOC(CH.sub.2).sub.p O--,R.sub.3 (CH.sub.2).sub.q O--或R.sub.4 [O(CH.sub.2).sub.2 ].sub.r O--,其中n为0-17,p为1-10,q为1-12,r为1-6,R.sub.3为1-或2-萘氧基,2,3-或3,4-二羟基苯基,苯基,苯氧基或取代苯基或苯氧基,其中取代基选自较低的烷基,较低的烷氧基,羟基,硝基,氨基,卤素,羧基或苯基,R.sub.4为较低的烷基;以及与碱形成的药学上可接受的盐。
  • Discotic compounds for use in liquid crystal mixtures
    申请人:Secretary of State for Defence in her Britannic Majesty's Government of
    公开号:US05750050A1
    公开(公告)日:1998-05-12
    Liquid crystal compounds have been synthesized of general formula (I) and may be mixed with other liquid crystal compounds to give useful liquid crystal mixtures which may then be used in liquid crystal devices. Such devices include linear and non-linear electrical, optical and electro-optical devices, magneto-optical devices and devices providing responses to stimuli such as temperature changes and total or partial pressure changes. Formula (I) where each Z.sub.1-6 is given by formula (II), where Y for each of Z.sub.1-6 is independently COO, OCO, CH.sub.2 O and OCH.sub.2, m defines the number of substituents on each of Z.sub.1-6 and is independently 0-5,and X is independently for each substituent on each of Z.sub.1-6 alkyl (straight chain, branched and chiral), alkoxy (straight chain, branched or chiral), alkanoyl (straight chain, branched or chiral), alkenyl (straight chain, branched or chiral), halogen, halogenoalkyl (straight chain, branched or chiral) and CN, provided that at least one of Z.sub.-6 1 has at least one substituent X, and excluding where m is 1 for each of Z.sub.1-6, Y is COO for each of Z.sub.1-6 and X is n-alkyl or n-alkoxy positioned para to Y for each of Z.sub.1-6 and also where M is 5 for each of Z.sub.1-6, Y is COO for each of Z.sub.1-6 and for each Z.sub.1-6 X is selected as n-alkoxy positioned para to Y and fluoride for all other substituents.
    已经合成了一般式(I)的液晶化合物,可以与其他液晶化合物混合,形成有用的液晶混合物,然后可以在液晶设备中使用。这些设备包括线性和非线性电学、光学和电光学设备、磁光学设备以及对温度变化和总体或局部压力变化等刺激提供响应的设备。公式(I)中,每个Z.sub.1-6由公式(II)给出,其中Z.sub.1-6的每个Y独立地为COO、OCO、CH.sub.2O和OCH.sub.2,m定义Z.sub.1-6的每个取代基的数量,独立地为0-5,X独立地为Z.sub.1-6的每个取代基选择烷基(直链、支链和手性)、烷氧基(直链、支链或手性)、烷酰基(直链、支链或手性)、烯基(直链、支链或手性)、卤素、卤素烷基(直链、支链或手性)和CN,前提是至少有一个Z.sub.-6 1具有至少一个取代基X,但不包括当m为1时,Z.sub.1-6的每个Y均为COO,Z.sub.1-6的每个取代基X均为在Y的对位上的n-烷基或n-烷氧基,以及当M为5时,Z.sub.1-6的每个Y均为COO,对于每个Z.sub.1-6,X均选择在Y的对位上的n-烷氧基,所有其他取代基均选择氟代物。
  • DISCOTIC COMPOUNDS FOR USE IN LIQUID CRYSTAL MIXTURES
    申请人:The Secretary of St. for Def. in her Britannic Maj. Governm of the Un. Kingdom of Gr. Brit. and N. Ireland
    公开号:EP0702668A1
    公开(公告)日:1996-03-27
  • Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display
    申请人:NIPPON OIL COMPANY, LIMITED
    公开号:EP0758013B1
    公开(公告)日:2000-10-11
  • US5298652A
    申请人:——
    公开号:US5298652A
    公开(公告)日:1994-03-29
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐